| AA | amino-acid |
| aFGF | acidic fibroblast growth factor |
| ALK1-7 | activin receptor-like kinases |
| Ang | angiopoietin |
| ANGPTL | angiopoietin-like protein |
| ApoE | apolipoprotein E |
| AQP4 | aquaporin 4 |
| BBB | blood–brain barrier |
| BTB | blood–brain tumor barrier |
| BTRE | brain tumor-related edema |
| bFGF | basic fibroblast growth factor |
| BM | bone marrow |
| BMDCs | bone-marrow-derived cells |
| BMP | bone morphogenetic protein |
| CNS | central nervous system |
| CXCL | chemokine C-X-C motif ligand |
| CXCR | CXC chemokine receptor |
| CCL | chemokine C-C motif ligand |
| CCR | CC chemokine receptor |
| DcR-3 | decoy receptor 3 |
| DR-3 | death receptor 3 |
| EC | endothelial cells |
| ECM | extracellular matrix |
| EGF | epidermal growth factor |
| eNOS | endothelial nitric oxide synthase |
| ERK | extracellular-signal-regulated kinase |
| FGF | fibroblast growth factor |
| GBM | glioblastoma multiforme |
| HGF | hepatocyte growth factor |
| HGG | high-grade gliomas |
| HIF-1 | hypoxia-inducible factor 1 |
| IDH | isocitrate dehydrogenase |
| IFN | interferon |
| IL | interleukin |
| IL-12 | interleukin-12 |
| IMG | intussusceptive microvascular growth |
| ICP | intracranial pressure |
| ITSs | interstitial/intervascular tissue structures |
| KDR | kinase domain receptor |
| LGG | low-grade gliomas |
| LOH | loss of heterozygosity |
| LPS | lipopolysaccharides |
| MIP-1 | monocyte chemoattractant protein-1 |
| MMPs | matrix metalloproteinases |
| MT-MMP | membrane-type matrix metalloproteinase |
| NK | natural killer |
| NO | nitric oxide |
| NRP1 | neuropilin |
| NVU | neurovascular units |
| PDGF | platelet-derived growth factor |
| PlGF | placental growth factor |
| PrGBM | primary GBM |
| SARS-CoV-2 | severe acute respiratory syndrome coronavirus 2 |
| ScGBM | secondary GBM |
| sNRP1 | soluble form of neuropilin |
| TAMs | tumor infiltrating macrophages |
| TEK | endothelial-specific receptor tyrosine kinase |
| TGF-α | transforming growth factor alpha |
| TGF-β | transforming growth factor-beta |
| Tie-1 | tyrosine kinase receptors with immunoglobulin-like and EGF-like domain 1 |
| TIMP | tissue inhibitor of metalloproteinases |
| TL1A | TNF-like ligand 1A |
| TMZ | temozolomide |
| TNFSF15 | TNF superfamily member 15 |
| TNF-α | tumor necrosis factor alpha |
| TβRIII | type III TGF-β co-receptor |
| uPA | urokinase-type plasminogen activator |
| VEGF | vascular endothelial growth factor |
| VEGFR-1 | receptor 1 for VEGF |
| VEGFR-2 | VEGF receptor-2 |
| VEGI | vascular endothelial growth inhibitor |
| VM | vascular mimicry |
| vSMCs | vascular smooth muscle cells |
| WHO | World Health Organization |